Insulet develops, manufactures, and markets the Omnipod Insulin Management System for people that have diabetes. This system ...
Insulet (NASDAQ:PODD – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research ...
Insulet Corp. closed 7.87% below its 52-week high of $289.46, which the company achieved on February 7th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback